Literature DB >> 14636882

Low-density lipoprotein subclass and its correlating factors in diabetics.

Woochang Lee1, Won-Ki Min, Sail Chun, Seongsoo Jang, Jin Q Kim, Do Hoon Lee, Joong Yeol Park, Hyosoon Park, Ji Eun Son.   

Abstract

OBJECTIVES: Small dense LDL, low density lipoprotein (LDL) particles with small size and high density, is regarded as a significant risk factor for cardiovascular diseases. Diabetes mellitus is one of the conditions accompanied by increased small dense LDL. We analyzed LDL subclass in type 2 diabetics and normal controls with LipoPrint LDL System to investigate the LDL heterogeneity in diabetics and factors affecting it. DESIGN AND METHODS: We selected 40 normal controls and 40 type 2 diabetics with fasting blood glucose level over 7.0 mmol/L and HbA1c level over 7%. LDL subclass was determined with LipoPrint LDL System. LipoPrint LDL System fractionates LDL into seven parts (LDL1-7) by size and LDL3 to LDL7 are defined as small-sized LDL. In addition we estimated 'the percent of small-sized LDL over whole LDL' and defined it as 'small-sized LDL proportion'.
RESULTS: Mean small-sized LDL proportion was significantly higher in diabetics (23.4%) than in controls (11.8%) (p<0.001) and small-sized LDL proportion showed positive correlation with blood levels of glucose, HbA1c, total cholesterol, triglyceride, and oxidized LDL and negative correlation with HDL cholesterol level in univariate analysis (p<0.001). Of these parameters, triglyceride, HbA1c, oxidized LDL were statistically significant variables contributing to the small-sized LDL proportion in stepwise multiple regression analysis.
CONCLUSIONS: We analyzed small-sized LDL proportion in type 2 diabetics and found that it was significantly increased in diabetics than control subjects and it was independently correlated with triglyceride, HbA1c, oxidized LDL in descending order, which are reflecting lipid metabolism, glycation, and oxidative stress, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636882     DOI: 10.1016/s0009-9120(03)00109-7

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.

Authors:  Sung Woo Kwon; Se-Jung Yoon; Tae Soo Kang; Hyuck Moon Kwon; Jeong-Ho Kim; Jihyuk Rhee; Sung-Ju Lee; Jong-Kwan Park; Jae Yun Lim; Young Won Yoon; Bum Kee Hong
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

2.  Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia.

Authors:  Ronald B Goldberg; John R Guyton; Theodore Mazzone; Ruth S Weinstock; Adam B Polis; Diane Tipping; Joanne E Tomassini; Andrew M Tershakovec
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 19.112

3.  LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Nobuyuki Taniguchi; Naoki Sakane
Journal:  Int J Prev Med       Date:  2012-03

4.  Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients.

Authors:  Sunghwan Suh; Hyung-Doo Park; Se Won Kim; Ji Cheol Bae; Alice Hyun-Kyung Tan; Hye Soo Chung; Kyu Yeon Hur; Jae Hyeon Kim; Kwang-Won Kim; Moon-Kyu Lee
Journal:  Diabetes Metab J       Date:  2011-10-31       Impact factor: 5.376

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.